Ocariza, Kakashca Faye L.

HRN: 24-37-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFTRIAXONE 1G (VIAL)
01/05/2024
01/11/2024
IV
800mg
OD
PCAP Severe
Waiting Final Action 
01/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2024
01/14/2024
IV
800mg
Q6hours
PCAP Severe; Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: